Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion.
Published
Other Article
Full Text
Duke Authors
- Blackwell, Kimberly Lynn
- Chen, Wei
- Hobeika, Amy Claudine
- Lyerly, Herbert Kim
- Morse, Michael Aaron
- Osada, Takuya
- Spector, Neil Lee
Cited Authors
- Hamilton, E; Blackwell, K; Hobeika, AC; Clay, TM; Broadwater, G; Ren, X-R; Chen, W; Castro, H; Lehmann, F; Spector, N; Wei, J; Osada, T; Lyerly, HK; Morse, MA
Published Date
- January 2013
Published In
Volume / Issue
- 11 /
Start / End Page
- 82 - 82
PubMed ID
- 23536971
Pubmed Central ID
- PMC:PMC3618320
Electronic International Standard Serial Number (EISSN)
- 1479-5876
International Standard Serial Number (ISSN)
- 1479-5876
Digital Object Identifier (DOI)
- 10.1186/1479-5876-11-82
Language
- eng